Shady Abohashem1,2, Michael T Osborne1,2, Tawseef Dar1,2, Nicki Naddaf2, Taimur Abbasi1,2, Ahmed Ghoneem2, Azar Radfar1,2, Tomas Patrich2, Blake Oberfeld2, Brian Tung2, Zahi A Fayad3, Sanjay Rajagopalan4, Ahmed Tawakol1,2. 1. Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Yawkey 5E, Boston, MA 02114-2750, USA. 2. Cardiovascular Imaging Research Center, Departments of Medicine and Imaging, Massachusetts General Hospital, 165 Cambridge St., Boston, MA 02114, USA. 3. BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave., New York, NY 10029, USA. 4. Department of Cardiovascular Medicine, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.
Abstract
AIMS: Air pollution [i.e. particulate matter with diameter <2.5 μm (PM2.5)] is a risk factor for major adverse cardiovascular events (MACE). While PM2.5 promotes leucopoiesis and atherosclerotic inflammation in experimental models, it is unknown whether this occurs in humans. We tested in humans (a) whether PM2.5 associates with higher leucopoietic tissue activity and arterial inflammation (ArtI), (ii) whether these associations persist after accounting for the effects of potential confounders including socioeconomics, traffic noise, and risk factors, and (iii) whether these tissue effects mediate the association between air pollution and MACE. METHODS AND RESULTS: Individuals (N = 503) without cardiovascular disease (CVD) or active malignancy underwent 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Major adverse cardiovascular event was adjudicated over 5 years of follow-up. Leucopoietic tissue activity (in bone marrow and spleen) as well as ArtI were measured. Annual PM2.5 levels were assessed at each individual's home address. At baseline, higher PM2.5 associated with increased leucopoietic activity [standardized (95% CI): 0.129 (0.042, 0.215), P = 0.004] as well as ArtI [0.088 (0.006, 0.171), P = 0.036] after adjusting for CVD risk factors. Over a median 4.1 years, 40 individuals experienced MACE. PM2.5 exposure associated with MACE [Cox HR (95% CI): 1.404 (1.135, 1.737), P = 0.002], remaining significant after adjustment for CVD risk factors and other potential confounders. Mediation analysis demonstrated that increased leucopoietic activity and ArtI serially mediate the link between PM2.5 exposure and MACE. CONCLUSIONS: Higher air pollution exposure associates with heightened leucopoietic activity and ArtI and independently predicts MACE through a biological pathway that includes higher leucopoietic activity and ArtI in series. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Air pollution [i.e. particulate matter with diameter <2.5 μm (PM2.5)] is a risk factor for major adverse cardiovascular events (MACE). While PM2.5 promotes leucopoiesis and atherosclerotic inflammation in experimental models, it is unknown whether this occurs in humans. We tested in humans (a) whether PM2.5 associates with higher leucopoietic tissue activity and arterial inflammation (ArtI), (ii) whether these associations persist after accounting for the effects of potential confounders including socioeconomics, traffic noise, and risk factors, and (iii) whether these tissue effects mediate the association between air pollution and MACE. METHODS AND RESULTS: Individuals (N = 503) without cardiovascular disease (CVD) or active malignancy underwent 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Major adverse cardiovascular event was adjudicated over 5 years of follow-up. Leucopoietic tissue activity (in bone marrow and spleen) as well as ArtI were measured. Annual PM2.5 levels were assessed at each individual's home address. At baseline, higher PM2.5 associated with increased leucopoietic activity [standardized (95% CI): 0.129 (0.042, 0.215), P = 0.004] as well as ArtI [0.088 (0.006, 0.171), P = 0.036] after adjusting for CVD risk factors. Over a median 4.1 years, 40 individuals experienced MACE. PM2.5 exposure associated with MACE [Cox HR (95% CI): 1.404 (1.135, 1.737), P = 0.002], remaining significant after adjustment for CVD risk factors and other potential confounders. Mediation analysis demonstrated that increased leucopoietic activity and ArtI serially mediate the link between PM2.5 exposure and MACE. CONCLUSIONS: Higher air pollution exposure associates with heightened leucopoietic activity and ArtI and independently predicts MACE through a biological pathway that includes higher leucopoietic activity and ArtI in series. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Yukinobu Goto; Hiroshi Ishii; James C Hogg; Chih-Horng Shih; Kazuhiro Yatera; Renaud Vincent; Stephan F van Eeden Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: David E Newby; Pier M Mannucci; Grethe S Tell; Andrea A Baccarelli; Robert D Brook; Ken Donaldson; Francesco Forastiere; Massimo Franchini; Oscar H Franco; Ian Graham; Gerard Hoek; Barbara Hoffmann; Marc F Hoylaerts; Nino Künzli; Nicholas Mills; Juha Pekkanen; Annette Peters; Massimo F Piepoli; Sanjay Rajagopalan; Robert F Storey Journal: Eur Heart J Date: 2014-12-09 Impact factor: 29.983
Authors: Tatsushi Suwa; James C Hogg; Kevin B Quinlan; Akira Ohgami; Renaud Vincent; Stephan F van Eeden Journal: J Am Coll Cardiol Date: 2002-03-20 Impact factor: 24.094
Authors: Ahmed Tawakol; Michael T Osborne; Ying Wang; Basma Hammed; Brian Tung; Tomas Patrich; Blake Oberfeld; Amorina Ishai; Lisa M Shin; Matthias Nahrendorf; Erica T Warner; Jason Wasfy; Zahi A Fayad; Karestan Koenen; Paul M Ridker; Roger K Pitman; Katrina A Armstrong Journal: J Am Coll Cardiol Date: 2019-07-02 Impact factor: 24.094
Authors: Marko Tainio; Audrey J de Nazelle; Thomas Götschi; Sonja Kahlmeier; David Rojas-Rueda; Mark J Nieuwenhuijsen; Thiago Hérick de Sá; Paul Kelly; James Woodcock Journal: Prev Med Date: 2016-05-05 Impact factor: 4.018
Authors: Amanda J Pappin; Tanya Christidis; Lauren L Pinault; Dan L Crouse; Jeffrey R Brook; Anders Erickson; Perry Hystad; Chi Li; Randall V Martin; Jun Meng; Scott Weichenthal; Aaron van Donkelaar; Michael Tjepkema; Michael Brauer; Richard T Burnett Journal: Environ Health Perspect Date: 2019-10-22 Impact factor: 9.031
Authors: Vanessa Frodermann; David Rohde; Gabriel Courties; Nicolas Severe; Maximilian J Schloss; Hajera Amatullah; Cameron S McAlpine; Sebastian Cremer; Friedrich F Hoyer; Fei Ji; Ian D van Koeverden; Fanny Herisson; Lisa Honold; Gustavo Santos Masson; Shuang Zhang; Jana Grune; Yoshiko Iwamoto; Stephen P Schmidt; Gregory R Wojtkiewicz; I-Hsiu Lee; Karin Gustafsson; Gerard Pasterkamp; Saskia C A de Jager; Ruslan I Sadreyev; Jean MacFadyen; Peter Libby; Paul Ridker; David T Scadden; Kamila Naxerova; Kate L Jeffrey; Filip K Swirski; Matthias Nahrendorf Journal: Nat Med Date: 2019-11-07 Impact factor: 53.440
Authors: Lauren H Wyatt; Anne M Weaver; Joshua Moyer; Joel D Schwartz; Qian Di; David Diaz-Sanchez; Wayne E Cascio; Cavin K Ward-Caviness Journal: Am Heart J Date: 2022-03-07 Impact factor: 5.099
Authors: Alberto Cecconi; Gonzalo Navarrete; Marcos Garcia-Guimaraes; Alberto Vera; Rafael Blanco-Dominguez; Ancor Sanz-Garcia; Marta Lozano-Prieto; Beatriz Lopez-Melgar; Fernando Rivero; Pilar Martin; Francisco Sanchez-Madrid; Hortensia de la Fuente; Luis Jesus Jimenez-Borreguero; Fernando Alfonso Journal: Sci Rep Date: 2022-03-30 Impact factor: 4.379